Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.250
+0.010 (0.31%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Rocket Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 49.61 | 77.56 | 163.64 | 55.9 | 140.52 | 232.69 |
Short-Term Investments | 94.77 | 111.37 | 208.7 | 317.27 | 215.88 | 156.05 |
Cash & Short-Term Investments | 144.38 | 188.93 | 372.34 | 373.18 | 356.39 | 388.74 |
Cash Growth | -54.62% | -49.26% | -0.22% | 4.71% | -8.32% | -19.47% |
Other Current Assets | 5.45 | 3.81 | 5.85 | 5.05 | 7.67 | 3.32 |
Total Current Assets | 149.83 | 192.73 | 378.18 | 378.22 | 364.06 | 392.06 |
Net Property, Plant & Equipment | 69.45 | 71.59 | 83.32 | 87.59 | 77.65 | 72.35 |
Other Intangible Assets | 25.15 | 25.15 | 25.15 | 25.15 | 25.72 | - |
Goodwill | 39.15 | 39.15 | 39.15 | 39.15 | 39.15 | 30.82 |
Long-Term Investments | - | - | - | 34.32 | 43.28 | - |
Other Long-Term Assets | 1.82 | 1.82 | 1.89 | 1.91 | 1.95 | 1.8 |
Total Assets | 285.41 | 330.45 | 527.7 | 566.34 | 551.81 | 497.02 |
Accounts Payable | 21.54 | 27.29 | 37.83 | 45.79 | 36.66 | 19.62 |
Current Portion of Leases | 2.92 | 2.92 | 2.86 | 2.72 | 2.51 | 2.55 |
Total Current Liabilities | 24.47 | 30.21 | 40.68 | 48.51 | 39.17 | 22.17 |
Long-Term Leases | 21.84 | 21.96 | 22.64 | 22.33 | 20.36 | 20.05 |
Other Long-Term Liabilities | 1.06 | 1.06 | 1.14 | 2.94 | 2.6 | 0.08 |
Total Long-Term Liabilities | 22.9 | 23.02 | 23.78 | 25.26 | 22.95 | 20.13 |
Total Liabilities | 47.37 | 53.23 | 64.47 | 73.77 | 62.12 | 42.3 |
Common Stock | 1.09 | 1.08 | 1.07 | 0.9 | 0.79 | 0.65 |
Treasury Stock | - | - | - | - | -0.05 | - |
Additional Paid-in Capital | 1,726 | 1,717 | 1,680 | 1,451 | 1,203 | 946.15 |
Accumulated Other Comprehensive Income | -0.11 | -0.03 | 0.07 | 0.32 | -0.36 | -0.16 |
Retained Earnings | -1,489 | -1,441 | -1,218 | -959.37 | -713.78 | -491.91 |
Shareholders' Equity | 238.04 | 277.22 | 463.23 | 492.57 | 489.69 | 454.72 |
Total Liabilities & Equity | 285.41 | 330.45 | 527.7 | 566.34 | 551.81 | 497.02 |
Total Debt | 24.76 | 24.88 | 25.5 | 25.04 | 22.87 | 22.6 |
Net Cash (Debt) | 119.62 | 164.05 | 346.84 | 348.13 | 333.53 | 366.14 |
Net Cash Growth | -27.09% | -52.70% | -0.37% | 4.38% | -8.91% | -13.04% |
Net Cash Per Share | 1.07 | 1.48 | 3.66 | 4.14 | 4.89 | 5.79 |
Book Value | 238.04 | 277.22 | 463.23 | 492.57 | 489.69 | 454.72 |
Book Value Per Share | 2.13 | 2.49 | 4.89 | 5.86 | 7.19 | 7.19 |
Tangible Book Value | 173.74 | 212.92 | 398.93 | 428.27 | 424.81 | 423.91 |
Tangible Book Value Per Share | 1.56 | 1.92 | 4.21 | 5.10 | 6.23 | 6.70 |